AUR1545

Customer Review

Based on 1 Customer Validation

AUR1545 is a selective KAT2A/KAT2B ((GCN5/PCAF)) PROTAC degrader that induces monocyte differentiation and inhibits the growth of acute myeloid leukemia cells. AUR1545 inhibits cell growth, induces epithelial differentiation and suppresses tumor growth in small cell lung cancer models. AUR1545 inhibits cell growth and induces differentiation in neuroendocrine prostate cancer cells and primary patient-derived organoids. AUR1545 is applicable to research related to acute myeloid leukemia, small cell lung cancer and neuroendocrine prostate cancer.
(Pink: GCN5/PCAF ligand (HY-W1122565); Blue: Cereblon ligand (HY-138793); Black: linker).

For research use only. We do not sell to patients.

  • Purity: 99.58%
  • CAS No.: 3031593-79-7
  • Formula: C41H50BrN9O5
  • Molecular Weight:828.80
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Histone Acetyltransferase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00